Workflow
金力泰: 董事会关于公司2024年度否定意见内部控制审计报告的专项说明

Core Viewpoint - Shanghai Jinlitai Chemical Co., Ltd. received a negative internal control audit report for the year 2024, indicating significant deficiencies in its internal control systems, particularly in financial management and procurement processes [1][4]. Group 1: Internal Control Deficiencies - The audit identified major defects in internal controls, particularly related to the management of funds and procurement processes, which were not effectively executed [1][3]. - A total of 931 million yuan was transferred to related traders, with 930 million yuan returned, indicating a lack of proper approval processes for significant payments [1][3]. - The company failed to effectively plan, decide, and approve the use of large amounts of returned funds, highlighting serious deficiencies in daily fund management [2][3]. Group 2: Board's Response - The board acknowledged the audit report as an objective reflection of the company's situation and recognized the professional judgment of the auditing firm [4]. - The board has identified the internal control deficiencies and included them in the self-evaluation report of internal controls [4]. Group 3: Improvement Measures - The company plans to optimize financial reporting processes and strengthen internal control supervision over significant business activities [5]. - There will be an emphasis on enhancing the audit department's functions to ensure effective execution of internal control systems [5]. - Training will be provided to management personnel to improve awareness of compliance with relevant laws and regulations [5].